Evaluation of urolithiasis in Crohn’s disease in Tunisian patients

##plugins.themes.academic_pro.article.main##

Houda Boussorra
Sataa Sallami
Yosra Said
Mohamed Chebil
Taoufik Najjar

Abstract

aim: To investigate the characteristics of urolithiasis associated with Crohn’s disease (CD) in a sample of Tunisian population.
methods: We retrospectively studied 184 patients with CD to reveal any urolithiasis during evolution. Evidence for the presence of renal calculi was obtained from plain films, ultrasonography or intravenous urography and computed tomography.
results: Renal calculi were found in only three patients with CD. All patients were woman. Mean time from diagnosis of CD to diagnosis of calculi was 22 months (range 6 to 48 months). Clinical features were not specific. Calculi were bilateral in two cases.
Conclusions: The rate of concurrent urolithiasis was very low in the present series of Tunisian patients. Although rare, efficient treatment and prevention of calculi formation are mandatory in CD patients’.

##plugins.themes.academic_pro.article.details##

References

  1. Ishii G, Nakajima K, Tanaka N, Hara H, Kato M, Ishii N. Clinical evaluation of urolithiasis in Crohn's disease. Int J Urol. 2009;16:477-80.
  2. Banner MP. Genitourinary complications of inflammatory bowel disease. Radiol Clin North Am. 1987; 25: 199-209.
  3. Sato S, Sasaki I, Naito H, et al. Management of urinary complications in Crohn's disease. Surg Today. 1999;29:713-7.
  4. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5-36.
  5. Magatonitis AN, Banner MP, Malkowicz BS. Urologic complication of Crohn's disease. Surg Clin North Am. 2001; 81:197-215.
  6. Caudarella R, Rizzoli E, Pironi L, et al. Renal stone formation in patients with inflammatory bowel disease. Scanning Microscopy. 1993; 7:371-80.
  7. McConnell N, Campbell S, Gillanders I, Rolton H, Danesh B. Risk factors for developing renal stones in inflammatory bowel disease. BJU Int. 2002;89:835-41.
  8. Shield DE, Lytton B, Weiss RM, Schiff M Jr. Urologic complications of inflammatory bowel disease. J Urol. 1976;115:701-6.
  9. Parmar MS. Kidney stones. BMJ. 2004;12:1420-4.
  10. McLeod RS, Churchill DN. Urolithiasis complicating inflammatory bowel disease. J Urol. 1992;148:974-8.
  11. Buño Soto A, Torres Jiménez R, Olveira A, Fernández-Blanco Herraiz I, Montero García A, Mateos Antón F. Lithogenic risk factors for renal stones in patients with Crohn's disease. Arch Esp Urol. 2001;54:282-92.
  12. Fukushima T, Yamazaki Y, Sugita A, Tsuchiya S. Prophylaxis of uric acid stone in patients with inflammatory bowel disease following extensive colonic resection. Gastroenterol Jpn. 1991; 26: 430-4.
  13. Siener R, Ebert D, Hesse A. Urinary oxalate excretion in female calcium oxalate stone formers with and without a history of recurrent urinary tract infections. Urol Res. 2001; 29: 245-8.
  14. Ito H, Miura N, Yamamoto K, Hara T. Reduction of oxalate content of foods by the oxalate degrading bacterium, Eubacterium lentum WYH-1. Int J Urol. 1996; 3:31-4.
  15. Kumer R, Mukherjee M, Bhandari M, Kumer A, Sidhu H, Mittal RD. Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol. 2002; 9:318-22.
  16. Nightingale J, Woodward JM. Small Bowel and Nutrition Committee of the British Society of Gastroenterology. Guidelines for management of patients with a short bowel. Gut. 2006;55:iv1-12.
  17. Pardi DS, Tremaine WJ, Sandborn WJ, McCarthy JT. Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol. 1998;93:504-14.
  18. Oikonomou K, Kapsoritakis A, Eleftheriadis T, Stefanidis I, Potamianos S. Renal manifestations and complications of inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:1034- 45.
  19. Worcester EM, Coe FL. Nephrolithiasis. Prim Care. 2008;35: 369-91.